An optimal sampling schedule for neonates, infants & children receiving cefazolin +/- vancomycin for cardiopulmonary bypass

Show simple item record Sturge, Jacqueline en Anderson, Brian en Holford, Nicholas en
dc.coverage.spatial Brisbane, Australia en 2016-10-27T23:26:15Z en 2016-08-22 en
dc.identifier.citation Poster session presented at the meeting of World Conference on Pharmacometrics (WCoP) 2016. Brisbane, Australia, 21-24 August 2016 en
dc.identifier.uri en
dc.description.abstract Background: Dosing of prophylactic antibiotics in children during cardiopulmonary bypass (CPB) remains poorly defined. Pharmacokinetic (PK) studies can be improved using optimal design when sampling is limited, or multiple factors influence PK. We aimed to optimize a sampling schedule designed to determine cefazolin and vancomycin PK in children undergoing CPB. Methods: A one compartment distribution model for vancomycin and a three compartment distribution model for cefazolin was used with theory based allometric scaling and maturation to describe first-order elimination clearance. The CPB circuit was represented by an additional compartment. We assumed 60 subjects received cefazolin 50, with 50 of these subjects undergoing a procedure with CPB. We assumed 15 subjects also received 15 vancomycin. Optimal times for up to 8 samples per patient were estimated, ignoring CPB effects, using WinPOPT (University of Otago, New Zealand). Optimal sampling times for determination of CPB related changes were considered separately. Designs were selected based on relative standard errors (RSEs) for model parameters and comparison of criterions summarizing design efficiency. Results: Sample times were 0.001, 0.001, 0.108, 0.36, 1.05, 1.85 h following the first dose, and 0.36 and 2.5 h after the second dose, for With CPB subjects. Sample times were 0.127, 0.43, 0.43, 1.3, 3.18, 6, 6 h after the first dose and 6 h after the second dose, for Without CPB subjects. Five samples, taken directly from the CPB circuit, were required to adequately capture CPB related changes in CPB V and CL. RSE estimates of cefazolin, vancomycin and CPB circuit parameters for the final design were ≤ 30%, with the exception of one of the cefazolin volumes (V2) for which RSEs were 49%. Conclusion: The sampling schedule may be used in the planning of a clinical study of children receiving cefazolin and vancomycin during CPB. en
dc.relation.ispartof World Conference on Pharmacometrics (WCoP) 2016 en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from en
dc.rights.uri en
dc.title An optimal sampling schedule for neonates, infants & children receiving cefazolin +/- vancomycin for cardiopulmonary bypass en
dc.type Conference Poster en
dc.description.version VoR – Version of Record en en
dc.rights.accessrights en
pubs.elements-id 541673 en Medical and Health Sciences en Medical Sciences en Pharmacology en School of Medicine en Anaesthesiology en
pubs.record-created-at-source-date 2016-09-23 en

Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record


Search ResearchSpace